OSPHOS INJECTION SOLUTION
Country: Canada
Language: English
Source: Health Canada
Patient Information leaflet
(PIL)
16-03-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CLODRONATE DISODIUM (CLODRONATE DISODIUM TETRAHYDRATE)
Available from:
DECHRA LTD
Dosage:
60MG
Pharmaceutical form:
SOLUTION
Composition:
CLODRONATE DISODIUM (CLODRONATE DISODIUM TETRAHYDRATE) 60MG
Administration route:
INTRAMUSCULAR
Units in package:
15ML
Prescription type:
Prescription
Therapeutic group:
HORSES
Product summary:
Active ingredient group (AIG) number: 0122982003
Authorization status:
APPROVED
Authorization date:
2015-05-06
